The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Pain and Multiple Sclerosis: Pathophysiology and Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trigeminal neuralgia: Pathology and pathogenesis
Love, S. (2001) · Brain · doi:10.1093/brain/124.12.2347 · Cited by 866
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500
ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.013 · Cited by 187
Research works printed but not linked: 88
- Paty DW, Ebers GC. Multiple sclerosis 135–191. Philadelphia: F.A. Davis Company; 1999. p. 135–91.
- Brichetto G, Messmer Uccelli M, Mancardi GL, Solaro C. Symptomatic medication use in multiple sclerosis. Mult Scler. 2003;9(5):458–60. · DOI
- "Part III: pain terms, a current list with definitions and notes on usage" (pp 209–214) Classification of chronic pain, second edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle; 1994. p. 209–14.
- Treede RD, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5. · DOI
- O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain. 2008;137:96–111. · DOI · Paper page
- Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol. 1984;41:1270–2. · DOI · Paper page
- Vermote R, Ketalaer P, Carltonn H. Pain in multiple sclerosis patients: a prospective study using the McGill pain questionnaire. Clin Neurol Neurosurg. 1986;88:87–93. · DOI
- Kassirer MR, Osterberg DH. Pain in chronic multiple sclerosis. J Pain Symptom Manage. 1987;2:95–7. · DOI
- Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology. 1988;38:1830–4. · DOI · Paper page
- Stenager E, Knutsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand. 1991;84:197–200. · DOI · Paper page
- Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axon. 1991;13:26–8.
- Archibald CJ, et al. Pain prevalence, severity and impact in a clinical sample of multiple sclerosis patients. Pain. 1994;58:89–93. · DOI · Paper page
- Indaco A, Iachetta C, Nappi C, Socci L, Carrieri PB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol. 1994;16:97–102.
- Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Ital J Neurol Sci. 1995;16:629–32. · DOI
- Beiske AG, Pedersen ED, Czujko B, Myhr KM. Pain and sensory complaints in multiple sclerosis. Eur J Neurol. 2004;1:479–82. · DOI
- Ehde DM, et al. Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler. 2003;6:605–11. · DOI · Paper page
- Svendsen KB, et al. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol. 2003;60:1089–94. · DOI · Paper page
- Solaro C, et al. The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study. Neurology. 2004;63:919–21. · DOI · Paper page
- Österberg A, Boivie J, Thomas KA. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain. 2005;9:531–42. · DOI · Paper page
- Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Mult Scler. 2006;12:629–38. · DOI
- Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007;127:35–41. · DOI · Paper page
- Piwko C, et al. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag. 2007;12:259–65. · doi:10.1155/2007/128681
- Khan F, Pallant J. Chronic pain in multiple sclerosis: prevalence, characteristics and impact on quality of life in an Australian community cohort. J Pain. 2007;8:614–23. · DOI · Paper page
- Boneschi M, et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler. 2008;14:514–21. · DOI
- Douglas C, Wollin J, Windsor C. Illness and demographic correlates of chronic pain among a community-based sample of people with multiple sclerosis. Arch Phys Med Rehabil. 2008;89:1923–32. · DOI
- Hirsh AT, Turner AP, Ehde DM, Haselkorn JK. Prevalence and impact of pain in multiple sclerosis: physical and psychological contributors. Arch Phys Med Rehabil. 2009;90:646–51. · DOI
- Seixa D, Vasco Galhardo MJ, Guimarães J, Lima L. Pain in Portuguese patients with multiple sclerosis. Front Neurol. 2011;2:20.
- Aicher SA, Silverman MB, Winkler CW, Bebo Jr BF. Hyperalgesia in an animal model of multiple sclerosis. Pain. 2004;110:560–70. · DOI
- • Olechowski CJ, Truong JJ, Kerr BJ. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain. 2009;141(1–2):156–64. This article reports the dysregulation of glutamate transport function in abnormal pain behavior in response to persistent noxious stimulation in EAE mice. · DOI · Paper page
- • Thibault K, Calvino B, Pezet S. Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain. 2011;15(3):231.e1–231.e16. This article reports the clinical signs linked to pain in two models of EAE related to time-course changes in disease representing a model of sensory abnormalities in MS. Thibault et al. also reported pain relief with medications such as gabapentin, duloxetine, and tramadol. · DOI
- Waxman SG. Acquired channelopathies in nerve injury and MS. Neurology. 2001;56(12):1621–7. 26. · DOI
- Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc Natl Acad Sci USA. 1999;96(14):7635–9. 6. · DOI · Paper page
- • Svendsen KB, Sørensen L, Jensen TS, Hansen HJ, Bach FW. MRI of the central nervous system in MS patients with and without pain. Eur J Pain. 2011;15(4):395–401. This study compares 13 subjects with MS with chronic pain and ten patients without pain. There was no association between chronic pain and the site of demyelinating lesions. · DOI
- Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Syst Rev. 2007; Issue 4. Art. No.: CD005454 doi: 10.1002/14651858.CD005454.pub2 . · DOI · Paper page
- Solaro C, Brichetto G, Battaglia MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci. 2005;25:307–10. · DOI
- Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia: use and side effects. Arch Neurol. 2001;19:129–36. · DOI · Paper page
- Shirzadi M, Alvestad S, Hovdal H, et al. Comparison of carbamazepine rash in multiple sclerosis and epilepsy. Acta Neurol Scand. 2012;125(1):60–3. · DOI
- Cianchetti C, Zuddas A, Randazzo AP, Perra L, Marrosu MG. Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology. 1999;53:433. · DOI
- Breuer B, et al. Randomized double-blind, placebo-controlled two period crossover pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther. 2007;29:2022–30. · DOI
- Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler. 1997;3:250–3. · DOI
- Rossi S, et al. Effects of Levetiracetam on chronic pain in multiple sclerosis: results of a randomized placebo-controlled study. Eur J Neurol. 2009;16:360–6. · DOI
- Solaro C, Boemker M, Tanganelli P. Pregabalin for treating paroxysmal symptoms in multiple sclerosis: a pilot study. J Neurol. 2009;256:1773–4. · doi:10.1007/s00415-009-5203-6
- Solaro C, Tanganelli P. Acute delirium in patients with multiple sclerosis treated with pregabalin. Clin Neuropharmacol. 2009;32:236–7. · doi:10.1097/01.wnf.0000265979.03198.33
- Herman RM, D’Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain. 1992;8:338–45. · doi:10.1097/00002508-199212000-00008
- Sadiq S, Poopatana C. Intrathecal basclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol. 2007;254:1464–5. · doi:10.1007/s00415-007-0566-z
- Kalman S, Österbergn A, Sörensenn J, Boivie J, Bertler A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine. Eur J Pain. 2002;6:69–80. · DOI
- Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology. 1995;45:1294–6. · DOI · Paper page
- • Mills RJ, Young CA, Smith ET. Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3T. Br J Radiol. 2010;83:493–8. The objective of this study was to determine the prevalence of trigeminal lesions using high-resolution MRI at 3T. Forty-seven patients with MS with a high prevalence of detectable trigeminal abnormalities were studied. MRI results did not correspond to trigeminal symptoms. · DOI
- •• Cruccu G, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain. 2009;143:186–91. MRI scans were performed on 130 patients with MS: 50 with trigeminal neuralgia, 30 with trigeminal sensory disturbances other than trigeminal neuralgia and 50 without pain. Cruccu et al. concluded that the most likely cause of MS-related trigeminal neuralgia is a pontine plaque damaging the primary afferents. Nevertheless, in some patients a neurovascular contact may act as a concurring mechanism. · DOI · Paper page
- Hutchins LG, Harnsberger HR, Jacobs JM, Apfelbaum RI. Trigeminal neuralgia (tic douloureux): MR imaging assessment. Radiology. 1990;175:837–41. · doi:10.1148/radiology.175.3.2343134
- Lazar ML, Kirkpatrick JB. Trigeminal neuralgia and multiple sclerosis: demonstration of the plaque in an operative case. Neurosurgery. 1979;5:711–7. · DOI
- Da Silva CJ, Da Rocha AJ, Mendes MF, Maja Jr ACM, Braga FT, Tilbery CP. Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients. Mult Scler. 2005;11:282–5. · DOI
- Nakashima I, Fujihara K, Kimpara T, Okita N, Takase S, Itoyama Y. Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imaging studies in 5 cases. Arch Neurol. 2001;58:101–4. · DOI
- Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology. 1997;49(4):1142–4. · DOI
- Meaney JFM, Watt JMG, Eldridge PR, Whitehouse GH, Wells JCD, Miles JB. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1995;59:253–9. · DOI
- Broggi G, Ferroli P, Franzini A, Nazzi V, Farina L, La Mantia L, Milanese C. Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis. Neurosurgery. 2004;55(4):830–8. discussion 838–9. · DOI
- Cruccu G, Leandri M, Feliciani M, Manfredi M. Idiopathic and symptomatic trigeminal pain. J Neurol Neurosurg Psychiatry. 1990;53(12):1034–42. · DOI
- Bergamaschi R, Romani A, Versino M, Callieco R, Gaspari D, Citterio A, Cosi V. Usefulness of trigeminal somatosensory evoked potentials to detect subclinical trigeminal impairment in multiple sclerosis patients. Acta Neurol Scand. 1994;89:412–4. · doi:10.1111/j.1600-0404.1994.tb02658.x
- Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ. 2000;320:1113. · DOI
- Leandri M, et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol. 2000;247:556–8. · DOI
- Solaro C, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology. 1998;51:609–11. · DOI
- Solaro C, Uccelli MM, Brichetto G, Gasperini C, Mancardi GL. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage. 2001;21:367–8. · doi:10.1016/s0885-3924(01)00275-5
- Solaro C, Uccelli MM, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol. 2000;44:45–8. · DOI
- DMKG Study Group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol. 2003;250(542–545). · DOI
- Lunardi G, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48:1714–7. · doi:10.1212/wnl.48.6.1714
- Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51:611–4. · DOI · Paper page
- Zvartau-Hind M, Din MU, Gilan A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology. 2000;55:1587–8. · DOI
- Reder AT, Arnason B. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995;45:1097–100. · DOI
- Linderoth B, Hakanson S. Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. Acta Neurol Scand. 1989;80:341–6. · doi:10.1111/j.1600-0404.1989.tb03890.x
- Kondziolka D, Lunsford LD, Bissonette DJ. Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can J Neurol Sci. 1994;21:137–40. · doi:10.1017/s0317167100049076
- Berk C, Constantoyannis C, Honey CR. The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can J Neurol Sci. 2003;30:220–3. · DOI
- Broggi G, Franzini A. Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain. J Neurosurg. 1982;57:483–6. · doi:10.3171/jns.1982.57.4.0483
- Rogers CL, et al. Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J Neurosurg. 2002;97 Suppl 5:529–32. · DOI
- Huang E, et al. Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients. Stereotact Funct Neurosurg. 2002;79:44–50. · doi:10.1159/000069503
- Broggi G, et al. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet. 1999;354:1878–9. · DOI
- Al-Araji AH, Oger J. Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult Scler. 2005;11:398–402. · DOI
- Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology. 2000;54:1368–70. · DOI
- Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler. 2000;6:192–3. · doi:10.1177/135245850000600310
- Solaro C, Tanganelli P. Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study. J Neurol Neurosurg Psychiatry. 2004;75:341.
- Restivo DA, Tinazzi M, Patti F, Palmeri A, Maimone D. Botulinum toxin treatment of painful tonic spasms in multiple sclerosis. Neurology. 2003;61:719–20. · DOI
- Thompson AJ. Symptomatic treatment in multiple sclerosis. Curr Opin Neurol. 1998;11:305–9. · DOI
- Solaro C, Messmer Uccelli M. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol. 2011;7:519–27. · DOI
- Lienau FS, Füllgraf H, Moser A, Feuerstein TJ. Why do cannabinoids not show consistent effects as analgesic drugs in multiple sclerosis? Eur J Neurol. 2007;14:1162–9. · DOI
- Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2010;29:135–41.
- Haythornthwaite JA, Benrud-Larsen LM. Psychological aspects of neuropathic pain. Clin J Pain. 2000;16:S101–5. · DOI · Paper page
- Duarte R. In: Kanner R, editor. Pain management secrets, vol. 6. Philadelphia: Hanley & Belfus; 2003.
- • Saverino A, Solaro C. Pain in individuals with multiple sclerosis, knee prosthesis, and post-herpetic neuralgia: learning from focus group patients' experience. Clin J Pain. 2012;28(4):300–8. Unique, spontaneous descriptors, possibly disease-specific, emerged in various focus groups of subjects with MS and other diseases. All disease groups used descriptors not included in the McGill Pain Questionnaire, underlining the need for assessment measures of pain based on individual perception. · DOI
- Vermote R, Ketalaer P, Carlton H. Pain in multiple sclerosis patients: a prospective study using the McGill Pain Questionnaire. Clin Neurol Neurosurg. 1986;88:87–93. · DOI
Cited by
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
Feinstein, A., Freeman, J., & Lo, A. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70231-5 · Cited by 281
Turcotte, D., Doupe, M., Torabi, M., Gomori, A., Ethans, K., Esfahani, F., Galloway, K., & Namaka, M. (2015) · Pain Medicine · doi:10.1111/pme.12569 · Cited by 124
Moisset, X., Ouchchane, L., Guy, N., Bayle, D. J., Dallel, R., & Clavelou, P. (2013) · Pain · doi:10.1016/j.pain.2013.07.050 · Cited by 86
Association Between Pain and Mindfulness in Multiple Sclerosis
Senders, A., Borgatti, A., Hanes, D., & Shinto, L. (2018) · International Journal of MS Care · doi:10.7224/1537-2073.2016-076 · Cited by 28
Metadata
- Authors
- Solaro, C., Trabucco, E., & Messmer Uccelli, M.
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2012-12-19
- Volume
- 13
- Issue
- 1
- Pages
- 320-320
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- OpenAlex
- W1970703427
- Cited by
- 177
- References
- 5
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pain and Multiple Sclerosis: Pathophysiology and Treatment. https://app.cochat.ai/papers/10.1007/s11910-012-0320-5
- The paper
- Solaro, C., Trabucco, E., & Messmer Uccelli, M. (2013). Pain and Multiple Sclerosis: Pathophysiology and Treatment. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-012-0320-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.